News
Conferences
- Virtual exhibitor at Discovery on Target Virtual, September 16-18, 2020
- Virtual exhibitor at Drug Discovery Chemistry (DDC) Virtual, August 25-28, 2020
- Exhibiting at ARVO 2020 Annual Meeting to be held May 3-7 2020 in Baltimore, MD at the Baltimore Convention Center
- Sponsor and poster presentation at the 4th Annual NASH summit 2020 to be held May 4-7, 2020 in Boston, MA
- Exhibiting at Society of Toxicology (SOT) 59th Annual Meeting & 2020 ToxExpo, to be held March 15 - 19, 2020 in Anaheim, California at the Anaheim Convention Center
- Exhibiting at World Pharma Week to be held June 2-4, 2020 in Boston. MA at the Hynes Convention Center
Events and Press Releases
-
Sep 2021
Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development
Read More
-
Sep 2021
Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
Read More
-
Mar 2021
Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add "off the shelf" PK profiling capabilities to its portfolio.
Read More
-
Jan 2021
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
Read More
-
Dec 2020
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
Read More
-
Aug 2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
Read More
-
Aug 2020
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.
Read More
-
May 2020
Medical Diagnostic Laboratories, L.L.C., Expands Availability of Coronavirus Disease 2019 (COVID-19) Testing into New York and Increases Testing Capabilities.
Read More
-
Nov 2019
Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development
Read More
-
Jun 2019
Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.
Read More
-
Feb 2019
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Read More
-
Oct 2018
Genesis Biotechnology Group announces partnership with Yale University
Read More
-
Jul 2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Read More
-
Mar 2017
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
Read More